US Biopharmaceutical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
BlockBeats News, July 28th, According to a report by businessinsider, Clinical-stage biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) today announced plans to strategically expand into the cryptocurrency and blockchain space.
The company plans to establish a subsidiary named "American BNB Strategy" to lead its digital asset investment and management plan. Through this platform, Liminatus plans to gradually raise and deploy up to $500 million in funds, with the goal of strategically long-term investing in BNB.
Liminatus emphasized that while the company remains fully committed to its core business - advancing cancer treatments and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
You may also like

Tether's major shareholder invests £12 million to support the "British version of Trump" in the cryptocurrency sector

Huang Renxun's Latest Podcast: Will NVIDIA Reach $1 Trillion? Will the Number of Programmers Increase Instead of Decrease? How to Deal with AI Anxiety?

Besides Resolv Hack, This DeFi Vulnerability Type Has Occurred Four Times

Trump Cries Peace, $1.5 Billion Dash | Rewire News Evening Brief

From x402 to MPP: Cloudflare's crucial vote, will it go to Coinbase or Stripe?

BlackRock CEO issues annual open letter: The wave of tokenization has arrived, and we will lead this trend

When Backpack backstabs the community

When gold is no longer a safe haven, and Bitcoin continues to panic

Trump, the World's Largest Oil Trader

If the US and Iran have not reached an agreement in 5 days, what other cards does Trump have?

Tether Whale Dumps £12 Million, Backing Crypto’s ‘British Trump’

Ethereum Foundation Post: Rethinking the Division of Work Between L1 and L2 to Build the Ultimate Ethereum Ecosystem

Two Major Prediction Market Platforms Unite Rarely, What Is the Story Behind This New Fund?

Dragonfly Partners: Most agents will not engage in autonomous trading, how can crypto payments prevail?

US AI Startup Goes All In on Chinese Mega-Model | Rewire News Morning Brief

Trump Lies Again: A "Five-Day Pause" Psyop, How Wall Street, Bitcoin, and Polymarket Insiders Synced Uposciogen

When a Token Becomes Labor, People Become the Interface

